Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

ABSTRACT: RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

PROVIDER: PRJEB31557 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor (24h treatment)

Project description:To identify the genes regulated by the Glucocorticoid Receptor (GR), we performed RNA-seq in GR18 cell line (derived from U2OS ATTC:HTB-96, stably transfected with an expression construct for GR), upon glucocorticoid (dexamethasone) or vehicle (ethanol) treatment for 24 hours.

2019-03-11 | E-MTAB-7745 | biostudies-arrayexpress

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

2018-10-29 | E-MTAB-6738 | biostudies-arrayexpress

synSTARR-seq with Glucocorticoid Receptor synthetic binding sites in GR18 cell line

Project description:We performed STARR-seq with synthetic libraries (synSTARR-seq) in GR18 cell line (derived from U2OS ATTC:HTB-96, stably transfected with an expression construct for GR), upon glucocorticoid (dexamethasone) or vehicle (ethanol) treatment. The synthetic libraries are variants of the glucocorticoid receptor binding sites (GBS). The "GBS half site" library contains 8 consecutive randomized nucleotides within the core binding sites, while the "Cgt/Sgk library" contains 5 consecutive randomized nucleotides on the flank of the GBS.

2018-10-29 | E-MTAB-6737 | biostudies-arrayexpress

RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

Project description:RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor

| PRJEB26484 | ENA

synSTARR-seq with Glucocorticoid Receptor synthetic binding sites in GR18 cell line

Project description:synSTARR-seq with Glucocorticoid Receptor synthetic binding sites in GR18 cell line

| PRJEB26483 | ENA

ChIP-seq for H3K27ac in the GR18 cell line treated for 1.5 h with 1 µM dexamethasone

Project description:We performed ChIP-seq in the GR18 cell line (derived from U2OS ATTC:HTB-96, stably transfected with an expression construct for GR), upon glucocorticoid (dexamethasone)treatment for 90 minutes. Cells were cross-linked with 1% formaldehyde for 3 minutes.

2019-03-11 | E-MTAB-7747 | biostudies-arrayexpress

ATAC-seq in GR18 cell line comparing cells treated for 90 minutes with 1 micro molar dexamethasone with vehicle (ethanol) control-treated cells

Project description:We performed ATAC-seq in the GR18 cell line (derived from U2OS ATTC:HTB-96, stably transfected with an expression construct for GR), upon glucocorticoid (dexamethasone) or vehicle (ethanol) treatment for 90 minutes.

2019-03-11 | E-MTAB-7746 | biostudies-arrayexpress

Reprogramming of glucocorticoid receptor function by hypoxia: RNA-seq after 24h.

Project description:Reprogramming of glucocorticoid receptor function by hypoxia: RNA-seq after 24h.

| PRJNA680767 | ENA

Glucocorticoid receptor gene expression profiling (BeadArray) in IMR90 cell line

Project description:To identify the sequences responsible for recruitment of Glucocorticoid receptor (GR) to individual loci, we performed BeadArray gene expression analysis in IMR90 cell line (ATTC:CCL-186), upon glucocorticoid treatment.

2015-02-25 | E-MTAB-2954 | biostudies-arrayexpress

NALP3 inflammasome up-regulation and CASP1 cleavage of the glucocorticoid receptor causes glucocorticoid resistance in leukemia cells [cell line Nalm6]

Project description:Glucocorticoids are universally used in the treatment of acute lymphoblastic leukemia (ALL), and glucocorticoid resistance in leukemia cells confers a poor prognosis. To elucidate mechanisms of glucocorticoid resistance, we determined the prednisolone sensitivity of primary leukemia cells from 444 newly diagnosed ALL patients and found significantly higher expression of caspase 1 (CASP1) and its activator NLRP3 in glucocorticoid resistant leukemia cells, due to significantly lower somatic methylation of CASP1 and NLRP3 promoters. Over-expression of CASP1 resulted in cleavage of the glucocorticoid receptor, diminished glucocorticoid-induced transcriptional response and increased glucocorticoid resistance. Knockdown or inhibition of CASP1 significantly increased glucocorticoid receptor levels and mitigated glucocorticoid resistance in CASP1 overexpressing ALL. Our findings establish a new mechanism by which the NLRP3/CASP1 inflammasome modulates cellular levels of the glucocorticoid receptor and diminishes cell sensitivity to glucocorticoids. The broad impact on glucocorticoid transcriptional response suggests this mechanism could also modify glucocorticoid effects in other diseases.

2015-03-24 | GSE66400 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data